What Is Cholesterol and Why Does Your Body Need It?
Cholesterol is an essential waxy, fat-like lipid produced primarily by the liver that serves as an indispensable physiological building block. Although often discussed exclusively in the context of cardiovascular disease, your body cannot function without it. Your liver synthesises approximately 75% to 80% of your body’s total cholesterol, with the remaining 20% to 25% absorbed from dietary animal products such as meat, seafood, poultry, and dairy.
Inside the body, cholesterol performs four vital physiological functions:
- Cellular Membrane Architecture: It integrates into the phospholipid bilayer of cell membranes throughout the human body, regulating membrane fluidity, permeability, and structural stability across fluctuating body temperatures.
- Steroid Hormone Synthesis: It serves as the biochemical precursor for essential steroid hormones, including sex hormones (oestrogen, progesterone, and testosterone) as well as adrenal corticosteroids (cortisol and aldosterone), which regulate stress responses, metabolism, and electrolyte balance.
- Vitamin D Production: Upon cutaneous exposure to ultraviolet B (UVB) sunlight, 7-dehydrocholesterol stored in the skin undergoes photolysis to create vitamin D, which supports skeletal bone mineralisation and immune health.
- Bile Acid Synthesis: The liver converts cholesterol into primary bile acids, which are concentrated in the gall bladder and secreted into the small intestine to emulsify and absorb dietary fats and fat-soluble vitamins (A, D, E, and K).
Because cholesterol is an oily, hydrophobic fat, it cannot dissolve in aqueous blood plasma. To circulate throughout the vascular system, the liver encapsulates hydrophobic cholesterol molecules and triglycerides within specialized transport spheres known as lipoproteins.
Understanding Your Blood Lipid Profile: LDL, HDL, and Triglycerides
A standard diagnostic lipid profile evaluates four primary blood components to assess cardiovascular risk. Interpreting these fractions individually gives doctors a comprehensive view of arterial plaque buildup versus protective cholesterol clearance.
- Low-Density Lipoprotein Cholesterol (LDL-C): Often referred to as “bad” cholesterol, LDL particles transport cholesterol from the liver to peripheral tissues. When circulating LDL levels become elevated, these particles penetrate the endothelial lining of blood vessels, oxidise, and provoke chronic vascular inflammation, laying down atheromatous plaques that narrow the arteries.
- High-Density Lipoprotein Cholesterol (HDL-C): Widely termed “good” cholesterol, HDL particles carry out reverse cholesterol transport. They scavenge excess, unneeded cholesterol from peripheral tissues and arterial linings and ferry it back to the liver for metabolic reprocessing or excretion through bile, offering a cardioprotective effect.
- Triglycerides: The most prevalent form of circulating fat in the body, triglycerides store unused dietary calories, excess refined carbohydrates, and alcohol. Elevated triglycerides thicken the blood, stimulate small dense LDL particle production, and heighten the risk of pancreatitis, heart attack, and ischaemic stroke.
- Total Cholesterol and Non-HDL Cholesterol: Total cholesterol measures the aggregate circulating cholesterol contained within all lipoprotein fractions. Non-HDL cholesterol (calculated as Total Cholesterol minus HDL-C) captures the cumulative burden of all atherogenic particles—including LDL, very-low-density lipoproteins (VLDL), and intermediate-density lipoproteins (IDL)—providing an accurate risk marker even in non-fasting assessments.
Target Cholesterol Levels in Malaysia (mmol/L and mg/dL)
In Malaysia, clinical laboratories and healthcare providers measure blood lipids primarily in millimoles per litre (mmol/L), while milligrams per decilitre (mg/dL) is frequently seen in international research. Individual target thresholds depend on a person’s total cardiovascular risk profile, as established by the Malaysian Ministry of Health (MOH) Clinical Practice Guidelines (CPG) on Dyslipidaemia Management.
The table below outlines standard clinical reference benchmarks used across Malaysian diagnostic laboratories and primary clinics:
| Lipid Component |
Desirable / Optimal Level |
Borderline / Moderate Risk |
High Risk / Elevated |
| Total Cholesterol (TC) |
< 5.2 mmol/L (< 200 mg/dL) |
5.2 – 6.2 mmol/L (200 – 239 mg/dL) |
> 6.2 mmol/L (> 240 mg/dL) |
| LDL Cholesterol (Low Risk) |
< 2.6 mmol/L (< 100 mg/dL) |
2.6 – 4.1 mmol/L (100 – 159 mg/dL) |
> 4.1 mmol/L (> 160 mg/dL) |
| LDL Cholesterol (High / Very High Risk) |
< 1.8 mmol/L (< 70 mg/dL) or ≥50% reduction |
1.8 – 2.5 mmol/L (70 – 99 mg/dL) |
≥ 2.6 mmol/L (≥ 100 mg/dL) |
| HDL Cholesterol (Men) |
> 1.0 mmol/L (> 40 mg/dL) |
0.9 – 1.0 mmol/L (35 – 40 mg/dL) |
< 0.9 mmol/L (< 35 mg/dL) |
| HDL Cholesterol (Women) |
> 1.2 mmol/L (> 50 mg/dL) |
1.0 – 1.2 mmol/L (40 – 50 mg/dL) |
< 1.0 mmol/L (< 40 mg/dL) |
| Fasting Triglycerides (TG) |
< 1.7 mmol/L (< 150 mg/dL) |
1.7 – 2.2 mmol/L (150 – 199 mg/dL) |
> 2.2 mmol/L (> 200 mg/dL) |
Under Malaysian CPG risk stratification, healthy adults with no cardiovascular risk factors target an LDL level below 2.6 mmol/L. Conversely, high-risk and very high-risk individuals—such as individuals with established coronary heart disease, previous stroke, diabetes mellitus with microvascular complications, or chronic kidney disease—must reach a stringent LDL target below 1.8 mmol/L (or achieve at least a 50% reduction from baseline) to prevent recurrent cardiovascular events.
The Silent Threat: Health Consequences of Hypercholesterolaemia
Hypercholesterolaemia is considered a silent health threat because elevated circulating lipids produce no physical pain, noticeable symptoms, or outward warning signs in their early stages. Most affected individuals feel entirely well until cumulative vascular damage precipitates an acute cardiac or cerebrovascular event.
Over years of sustained lipid elevation, excess LDL particles cross into the damaged arterial intima, undergoing chemical oxidation. Circulating white blood cells ingest these oxidised lipids, turning into foam cells that form fatty streaks. Over time, calcium, collagen, and cellular debris accumulate over these streaks, developing into rigid, fibrous atheromatous plaques—a pathological process known as atherosclerosis.
Atherosclerosis narrows arterial channels and degrades vessel elasticity. In coronary arteries, reduced oxygen delivery causes angina (exertional chest discomfort). If a fibrous plaque ruptures, platelets aggregate instantly over the exposed core, forming a blood clot (thrombus) that can completely block coronary perfusion within minutes, triggering an acute myocardial infarction (heart attack). When this process occurs in carotid or cerebral vessels, it causes an ischaemic stroke.
In Malaysia, this dynamic represents a severe public health challenge. According to the National Health and Morbidity Survey (NHMS) 2023, 33.3% of Malaysian adults—or roughly 7.6 million people—live with hypercholesterolaemia. A substantial portion of these individuals, particularly working adults under age 40, are unaware of their condition. Cardiovascular disease remains the leading cause of premature mortality across Malaysian public and private hospitals, with local patients suffering acute coronary syndromes at an average age of 56 to 58 years—nearly a decade younger than patients in Western countries.
Root Causes and Major Risk Factors Behind High Cholesterol
High cholesterol develops from an interplay of modifiable daily habits, secondary metabolic disorders, and inherited genetic mutations. Pinpointing an individual’s root risk drivers helps clinicians choose between therapeutic lifestyle modifications alone or combined pharmacotherapy.
- Saturated and Trans Fat-Heavy Diets: Diets high in saturated fatty acids stimulate the liver’s hepatic production of LDL while down-regulating surface LDL receptors. In Malaysia, frequent consumption of deep-fried hawker food, repeated-use cooking oils, organ meats, processed meats, full-fat dairy, and curries made with thick coconut milk (santan) drives elevated LDL.
- Physical Inactivity and Sedentary Behaviour: A lack of consistent aerobic exercise depresses the activity of lipoprotein lipase, an enzyme responsible for clearing circulating triglycerides. The NHMS survey observed that roughly half of Malaysian adults lead sedentary daily lives, a lifestyle pattern that directly suppresses protective HDL-C.
- Central Adiposity and Excess Weight: Carrying surplus adipose tissue, particularly visceral abdominal fat, triggers elevated free fatty acid influx into the liver, stimulating excessive VLDL production and driving high triglycerides alongside low HDL-C.
- Cigarette Smoking and Vaping: Tobacco chemicals, particularly acrolein, inhibit the enzymatic activity of lecithin-cholesterol acyltransferase (LCAT), which neutralises HDL’s protective properties, oxidises circulating LDL, and injures the arterial lining.
- Familial Hypercholesterolaemia (FH): An inherited monogenic disorder caused by mutations in the LDLR, APOB, or PCSK9 genes that prevents normal liver clearance of LDL particles. Affecting approximately 1 in every 100 Malaysians, FH causes severely elevated LDL levels from birth and can cause early heart attacks even in lean, active individuals.
- Secondary Metabolic Conditions: Co-occurring chronic illnesses including Type 2 diabetes mellitus, hypothyroidism, obstructive liver disease, and chronic kidney disease significantly disrupt systemic lipid clearance and metabolism.
Practical Malaysian Dietary and Lifestyle Modifications to Lower Cholesterol
Implementing structured dietary shifts and regular exercise provides the foundation for managing borderline-to-moderate dyslipidaemia. Adapting everyday Malaysian meal selections and preparation techniques can lower circulating LDL-C and improve overall metabolic health.
- Increase daily soluble fibre intake: Soluble fibre binds to cholesterol-rich bile salts in the small intestine, carrying them out through waste excretion and prompting the liver to draw down circulating blood cholesterol to replenish bile acids. Consume at least 3 grams of oat beta-glucan daily, alongside barley, beans, lentils, and locally available high-fibre vegetables such as bendi (okra), brinjal (eggplant), and leafy Malaysian ulam (pegaga, ulam raja).
- Substitute cooking fats and moderate coconut milk (santan): Cut down on repeated-use palm oil for deep-frying and limit heavy santan gravies. Prepare curries and soups using low-fat milk, unflavoured Greek yoghurt, or plant milk substitutes. When home cooking, switch to monounsaturated oils such as canola or olive oil.
- Incorporate local omega-3-rich oily fish: Eat oily fish at least twice a week. Affordable, locally caught Malaysian fish such as ikan kembung (mackerel), ikan tenggiri (Spanish mackerel), and ikan siakap contain rich reserves of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that lower circulating serum triglycerides.
- Cut refined carbohydrates and added sugars: High intake of refined flour and sugary beverages—such as condensed milk teh tarik, sweetened iced coffees, bubble tea, and syrup drinks—prompts the liver to convert excess glucose into triglycerides. Transition to unsweetened drinks (teh O kosong, plain water) and unrefined complex carbohydrates such as brown rice, whole oats, and multigrain bread.
- Accumulate 150 minutes of moderate aerobic exercise weekly: Engage in moderate-intensity physical activity—such as brisk walking, swimming, outdoor cycling, or badminton—for 30 minutes a day, 5 days per week. Sustained aerobic movement raises cardioprotective HDL-C and accelerates triglyceride clearance.
- Maintain a healthy Asian BMI and stop smoking: Strive to maintain a Body Mass Index (BMI) within the healthy Asian threshold of 18.5 to 22.9 kg/m², maintaining waist circumferences under 90 cm for men and 80 cm for women. Ceasing tobacco use eliminates arterial endothelial damage and restores circulating HDL-C levels within several weeks.
Medical Treatments: When Are Cholesterol-Lowering Drugs Prescribed?
Cholesterol-lowering medications are clinically prescribed when targeted lifestyle adjustments fail to achieve safe lipid targets after a 3 to 6-month trial, or when an individual’s overall cardiovascular risk profile warrants prompt pharmacological intervention. Under Malaysian CPG protocols, doctors calculate a patient’s 10-year risk of cardiovascular disease using tools such as the Framingham General Cardiovascular Risk Score.
Individuals presenting with established cardiovascular disease, Type 2 diabetes with organ complications, or baseline LDL levels exceeding 4.9 mmol/L do not require preliminary score calculations; they are initiated on medical therapy alongside therapeutic lifestyle changes right away.
The primary classes of lipid-lowering pharmacotherapy include:
- Statins (HMG-CoA Reductase Inhibitors): The established first-line drug therapy worldwide. Common statins include atorvastatin, rosuvastatin, and simvastatin. Statins work by inhibiting hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting liver enzyme responsible for cholesterol synthesis. By lowering intracellular cholesterol, hepatocytes upregulate cell-surface LDL receptors to clear circulating LDL from the bloodstream. Statins also provide pleiotropic benefits, including dampening vascular inflammation and stabilising vulnerable plaques against rupture.
- Cholesterol Absorption Inhibitors (Ezetimibe): Ezetimibe acts locally on the brush border of the small intestine to inhibit the Niemann-Pick C1-Like 1 (NPC1L1) transporter protein, blocking dietary and biliary cholesterol absorption. Frequently co-prescribed with statins, ezetimibe provides an incremental 15% to 20% reduction in LDL-C without requiring higher statin doses.
- PCSK9 Inhibitors and Novel Biologics: For patients with severe familial hypercholesterolaemia or clinical statin intolerance, injectable monoclonal antibodies (such as evolocumab and alirocumab) or small interfering RNA therapies (inclisiran) target PCSK9 proteins. By preventing the enzymatic degradation of liver LDL receptors, these agents lower refractory LDL levels by 50% to 60%.
Medication compliance is vital; cholesterol-lowering drugs work only while taken consistently and are never a replacement for a healthy diet and active lifestyle.
Screening and Diagnosis: When and Where to Get Tested in Malaysia
Routine diagnostic screening is the only reliable method to identify hypercholesterolaemia before cardiovascular complications emerge. Blood tests quantify circulating lipid concentrations, giving healthcare professionals objective data to calculate overall cardiovascular risk.
- Recommended Screening Frequency: Malaysian health authorities recommend that all healthy adults aged 30 and older undergo a baseline lipid profile at least once every 1 to 2 years. Individuals with pre-existing risk factors—such as a family history of premature heart disease, obesity, high blood pressure, or diabetes—should begin annual lipid panels starting at age 18 to 20.
- Pre-Test Fasting Protocol: A standard full lipid profile traditionally calls for 8 to 10 hours of overnight fasting prior to venous blood collection. During this window, food, milk, tea, coffee, and alcohol must be avoided; drinking plain water is encouraged to prevent dehydration and facilitate smooth venepuncture. Non-fasting lipid tests are increasingly accepted for routine initial risk checks, but an overnight fast remains standard whenever precise triglyceride evaluation is required.
- Where to Get Screened Across Malaysia:
- Public Primary Care (Klinik Kesihatan): Government health clinics provide accessible, subsidised lipid profile testing nationwide. Furthermore, eligible low-income Malaysians can access fully sponsored health screening packages via the government PeKa B40 scheme at registered public and private partner clinics.
- Private General Practitioner (GP) Clinics: Local community GP clinics offer quick, walk-in lipid panels, with results usually returned within 24 to 48 hours via accredited commercial pathology laboratories.
- Private Diagnostic Labs and Hospital Screening Centres: Walk-in diagnostic laboratories (such as Pathlab, BP Healthcare, and Innoquest) and private tertiary medical centres offer comprehensive executive screening packages that combine lipid profiles with blood glucose, renal profiles, liver function tests, and resting electrocardiograms (ECGs).
Frequently Asked Questions
Can skinny or athletic individuals have high cholesterol?
Yes. While being overweight or physically inactive raises your risk of dyslipidaemia, body mass does not solely dictate circulating cholesterol levels. Up to 80% of circulating cholesterol is manufactured internally by the liver rather than derived directly from body fat stores. Genetic conditions such as Familial Hypercholesterolaemia (FH), thyroid disorders, underlying chronic kidney disease, poor dietary quality, and chronic mental stress can cause dangerously elevated LDL levels in individuals who appear physically lean and fit.
Does eating whole eggs raise blood cholesterol dangerously?
For most people, eating whole eggs in moderation does not significantly elevate blood LDL cholesterol or cardiovascular disease risk. Although egg yolks are rich in dietary cholesterol (around 180 to 200 mg per large egg), dietary cholesterol has a far smaller impact on blood LDL than saturated fats and industrial trans fats. In healthy adults, the liver compensates for dietary cholesterol intake by dialling down its own internal production. Consuming 1 to 2 whole eggs daily as part of a balanced diet is considered safe for the majority of the population.
How long must I fast before a cholesterol blood test?
Standard diagnostic full lipid profiles typically require an overnight fast of 8 to 10 hours. During this period, you must avoid all food, caloric beverages, dairy, and alcohol, although drinking generous amounts of plain water is actively encouraged to keep your veins hydrated. While current clinical guidelines permit non-fasting blood draws for initial cardiovascular risk screening and total cholesterol checks, fasting is still preferred when calculating baseline fasting triglycerides and evaluating specific secondary lipid disorders.
Can high cholesterol be permanently cured without medication?
High cholesterol cannot be “permanently cured” in the way an infection is eradicated, because lipid regulation is an ongoing metabolic process. Mild to moderate elevations driven primarily by poor diet or lack of exercise can often be successfully normalised and kept in check through sustained dietary discipline, weight management, and routine exercise. However, individuals with inherited genetic conditions like Familial Hypercholesterolaemia or those with established cardiovascular disease require lifelong medical surveillance and ongoing pharmacotherapy to prevent heart attacks and strokes.
Sources
- businesstoday.com.my
- slideshare.net
- gleneagles.com.my
- mims.com
- nih.gov
- slideshare.net
- protecthealth.com.my
- says.com
- galencentre.org
- nih.gov
- nih.gov
- nih.gov
- e-mjm.org
- ringgitplus.com
- hisential.com
